Study on the immunosuppression effects after iodine-131 treatment in patients with differentiated thyroid carcinoma

被引：0
|
作者：
Luo, QY [1 ]
Yu, YL [1 ]
Chen, LB [1 ]
Lu, HK [1 ]
Zhu, RS [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Sixth Peoples Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2004年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S426 / S427
页数：2
相关论文
共 50 条
  • [1] Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma
    Fard-Esfahani, Armaghan
    Emami-Ardekani, Alireza
    Fallahi, Babak
    Fard-Esfahani, Pezhman
    Beiki, Davood
    Hassanzadeh-Rad, Arman
    Eftekhari, Mohammad
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2014, 35 (08) : 808 - 817
  • [2] Differentiated Thyroid Carcinoma After Iodine-131 Metaiodobenzylguanidine Treatment for Neuroblastoma: Assessment of Causality
    Teszler, Chris Barna
    [J]. THYROID, 2013, 23 (02) : 248 - 249
  • [3] Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma
    MKacher, R
    Legal, JD
    Schlumberger, M
    Aubert, B
    BeronGaillard, N
    Gaussen, A
    Parmentier, C
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (03) : 377 - 380
  • [4] Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma
    Muratet, JP
    Giraud, P
    Daver, A
    Minier, JF
    Gamelin, E
    Larra, F
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (09) : 1362 - 1368
  • [5] Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma
    MKacher, R
    Legal, JD
    Schlumberger, M
    Voisin, P
    Aubert, B
    Gaillard, N
    Parmentier, C
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (11) : 1860 - 1864
  • [6] Differentiated Thyroid Carcinoma After Iodine-131 Metaiodobenzylguanidine Treatment for Neuroblastoma: Assessment of Causality Response
    van Santen, Hanneke M.
    Tytgat, Godelieve A. M.
    de Wetering, Marianne D. van
    van Eck-Smit, Berthe L. F.
    Hopman, Saskia M. J.
    van der Steeg, Alida F.
    van Dijkum, Els J. M. Nieveen
    van Trotsenburg, A. S. Paul
    [J]. THYROID, 2013, 23 (02) : 249 - 249
  • [7] Iodine-131 Therapy Complications In Mother And Child In Patients With Differentiated Thyroid Carcinoma
    Fard-Esfahani, A.
    Fallahi, B.
    Hadifar, M.
    Ansari, K.
    Beiki, D.
    Eftekhari, M.
    Saghari, M.
    Takavar, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S223 - S223
  • [8] Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma
    Leger, FA
    Izembart, M
    Dagousset, F
    Barritault, L
    Baillet, G
    Chevalier, A
    Clerc, J
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (03) : 242 - 246
  • [9] Conception after iodine-131 therapy for differentiated thyroid cancer
    Ayala, C
    Navarro, E
    Rodriguez, JR
    Silva, H
    Venegas, E
    Astorga, R
    [J]. THYROID, 1998, 8 (11) : 1009 - 1011
  • [10] Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma
    Françoise Aubène Leger
    Mireille Izembart
    Françoise Dagousset
    Lionel Barritault
    Georges Baillet
    Alain Chevalier
    Jérôme Clerc
    [J]. European Journal of Nuclear Medicine, 1998, 25 : 242 - 246
12345